Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works

DNA Vaccines: Immunology, Application, and Optimization

Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,198 · see citing works

Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation

Huang, M., Khor, E., & Lim, L. Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016249.52831.a5 · Cited by 853 · see citing works

Chitosan as a novel nasal delivery system for vaccines

Illum, L., Jabbal‐Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 756 · see citing works

The Population Dynamics and Control of Tuberculosis

Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604 · see citing works

DNA-polycation nanospheres as non-viral gene delivery vehicles

Leong, K. W., Mao, H., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00252-6 · Cited by 538 · see citing works

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

Vila, A., Sánchez, A., Janes, K. A., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449 · see citing works

Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport

Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 373 · see citing works

ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis

Brandt, L., Elhay, M. J., Rosenkrands, I., Lindblad, E. B., & Andersen, P. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.791-795.2000 · Cited by 336 · see citing works

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

Sette, A., & Fikes, J. D. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00083-9 · Cited by 323 · see citing works

ESAT-6 proteins: protective antigens and virulence factors?

Brodin, P., Rosenkrands, I., Andersen, P., Cole, S. T., & Brosch, R. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.09.007 · Cited by 312 · see citing works

New vaccines for tuberculosis

Kaufmann, S. H. E., Hussey, G. D., & Lambert, P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 297 · see citing works

Modulating the immune response with dendritic cells and their growth factors

Pulendran, B., Banchereau, J., Maraskovsky, E., & Maliszewski, C. R. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01794-4 · Cited by 263 · see citing works

Chitosan-based nanoparticles for topical genetic immunization

Cui, Z., & Mumper, R. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00407-2 · Cited by 257 · see citing works

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

van Dissel, J. T., Arend, S. M., Prins, C., Bang, P. F., Tingskov, P. N., Lingnau, K., Nouta, J., Klein, M. R., Rosenkrands, I., Ottenhoff, T. H. M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.094 · Cited by 203 · see citing works

Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting

Fahmy, T. M., Samstein, R. M., Harness, C. C., & Saltzman, W. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.025 · Cited by 194 · see citing works

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination

Slütter, B., Plapied, L., Fievez, V., Alonso, M. J., Rieux, A. D., Schneider, Y., van Riet, E., Jiskoot, W., & Véronique Préat, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.011 · Cited by 192 · see citing works

Mycobacterium tuberculosis secretory proteins CFP‐10, ESAT‐6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide‐induced NF‐κB transactivation by downregulation of reactive oxidative species (ROS) production

Ganguly, N., Giang, P. H., Gupta, C., Basu, S. K., Siddiqui, I., Salunke, D. M., & Sharma, P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100117 · Cited by 183 · see citing works

Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine

Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P., Higgins, T. J., Ciccarelli, R. B., Evans, M., Man, S., Smith, L. R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5366 · Cited by 182 · see citing works

Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity

Dietrich, J., Andersen, C. S., Rappuoli, R., Doherty, T. M., Jensen, C. G., & Andersen, P. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6353 · Cited by 180 · see citing works

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner

Chatterjee, S., Dwivedi, V. P., Singh, Y., Siddiqui, I., Sharma, P., Van Kaer, L., Chattopadhyay, D., & Das, G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002378 · Cited by 153 · see citing works

Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B

Khatri, K., Goyal, A. K., Gupta, P. N., Mishra, N., & Vyas, S. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.027 · Cited by 140 · see citing works

Influence of ESAT-6 Secretion System 1 (RD1) of Mycobacterium tuberculosis on the Interaction between Mycobacteria and the Host Immune System

Majlessi, L., Brodin, P. M., Brosch, R., Rojas, M.-J., Khun, H., Huerre, M., Cole, S. T., & Leclerc, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3570 · Cited by 128 · see citing works

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection

van Dissel, J. T., Soonawala, D., Joosten, S. A., Prins, C., Arend, S. M., Bang, P. F., Tingskov, P. N., Lingnau, K., Nouta, J., Hoff, S. T., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.135 · Cited by 122 · see citing works

The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation

Sette, A., Livingston, B. D., McKinney, D. M., Appella, E., Fikes, J. D., Sidney, J., Newman, M. J., & Chesnut, R. W. (2001) · Biologicals · doi:10.1006/biol.2001.0297 · Cited by 112 · see citing works

Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

Chua, B. Y. L., Kobaisi, M. A., Zeng, W., Mainwaring, D. E., & Jackson, D. C. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200264m · Cited by 108 · see citing works

Induction of CD8 T Cells against a Novel Epitope in TB10.4: Correlation with Mycobacterial Virulence and the Presence of a Functional Region of Difference-1

Billeskov, R., Lundberg, C. V., Andersen, P. L., & Dietrich, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3973 · Cited by 100 · see citing works

Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice

Bal, S. M., Slütter, B., Verheul, R. J., Bouwstra, J. A., & Jiskoot, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.003 · Cited by 98 · see citing works

Quality and Vaccine Efficacy of CD4+ T Cell Responses Directed to Dominant and Subdominant Epitopes in ESAT-6 from Mycobacterium tuberculosis

Aagaard, C., Hoang, T. T. K. T., Lundberg, C. V., Dietrich, J., & Andersen, P. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900947 · Cited by 89 · see citing works

Developing an epitope-driven tuberculosis (TB) vaccine

DEGROOT, A., McMurry, J. A., Marcon, L., FRANCO, J., Rivera, D. S., Kutzler, M. A., WEINER, D., & MARTIN, B. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.059 · Cited by 84 · see citing works

Current status of TB vaccines

Gupta, U. D., Katoch, V. M., & McMurray, D. N. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.112 · Cited by 81 · see citing works

A protein linkage map of the ESAT-6 secretion system 1 (ESX-1) of Mycobacterium tuberculosis

Teutschbein, J., SCHUMANN, G., Möllmann, U., Grabley, S., Cole, S. T., & Münder, T. (2007) · Microbiological Research · doi:10.1016/j.micres.2006.11.016 · Cited by 75 · see citing works

Alteration of epitope recognition pattern in Ag85B and ESAT‐6 has a profound influence on vaccine‐induced protection against Mycobacterium tuberculosis

Bennekov, T., Dietrich, J., Rosenkrands, I., Stryhn, A., Doherty, T. M., & Andersen, P. L. (2006) · European Journal of Immunology · doi:10.1002/eji.200636128 · Cited by 71 · see citing works

Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine

Neimert-Andersson, T., Hällgren, A.-C., Andersson, M., Langebäck, J., Zettergren, L., Nilsen‐Nygaard, J., Draget, K. I., van Hage, M., Lindberg, A. A., Gafvelin, G., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.041 · Cited by 66 · see citing works

Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS

Borsuk, S., Newcombe, J., Mendum, T. A., Dellagostin, O. A., & McFadden, J. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.07.003 · Cited by 66 · see citing works

Screening of Predicted Secreted Antigens fromMycobacterium bovisReveals the Immunodominance of the ESAT-6 Protein Family

Jones, G. J., Gordon, S. V., Hewinson, R. G., & Vordermeier, H. M. (2010) · Infection and Immunity · doi:10.1128/iai.01246-09 · Cited by 57 · see citing works

Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection

Yu, F., Wang, J., Dou, J., Yang, H., He, X., Xu, W., Zhang, Y., Hu, K., & Gu, N. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.02.015 · Cited by 55 · see citing works

Childhood tuberculosis: old and new vaccines

Hussey, G. D., Hawkridge, T., & Hanekom, W. A. (2007) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2007.04.009 · Cited by 49 · see citing works

Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine

Yang, Y., Chen, J., Li, H., Wang, Y., Xie, Z., Wu, M., Zhang, H., Zhao, Z., Chen, Q., Fu, M.-L., et al. (2006) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2006.09.006 · Cited by 40 · see citing works

Stimulation of Hematopoiesis by the Fms-Like Tyrosine Kinase 3 Ligand Restores Bacterial Induction of Th1 Cytokines in Thermally Injured Mice

Toliver-Kinsky, T. E., Lin, C. Y., Herndon, D. N., & Sherwood, E. R. (2003) · Infection and Immunity · doi:10.1128/iai.71.6.3058-3067.2003 · Cited by 40 · see citing works

Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-α induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice

Shen, H., Wang, C., Yang, E., Xu, Y., Liu, W., Yan, J., Wang, F., & Wang, H. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00232.x · Cited by 31 · see citing works

Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice

Wang, F., He, X., Jiang, L., Ren, D., He, Y., Li, D., & Sun, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.11.042 · Cited by 28 · see citing works

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice

Xu, J., Xu, W., Chen, X., Zhao, D., & Wang, Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.044 · Cited by 22 · see citing works

Subcutaneous Administration of Modified Vaccinia Virus Ankara Expressing an Ag85B‐ESAT6 Fusion Protein, but Not an Adenovirus‐Based Vaccine, Protects Mice Against Intravenous Challenge with Mycobacterium tuberculosis

You, Q., Jiang, C., Wu, Y., Yu, X., Chen, Y., Zhang, X., Wei, W., Wang, Y., Tang, Z., Jiang, D., et al. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02629.x · Cited by 20 · see citing works

Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant

Zhou, Q., Wang, F., Yang, F., Wang, Y., Zhang, X., & Sun, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.006 · Cited by 20 · see citing works

Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs

McCormick, S. M., Santosuosso, M., Small, C.-L. N., Shaler, C. R., Zhang, X., Jeyanathan, M., Mu, J., Takenaka, S., Ngai, P., Gauldie, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2356 · Cited by 17 · see citing works

Improved Immunogenicity of Recombinant Mycobacterium bovis Bacillus Calmette‐Guérin Strains Expressing Fusion Protein Ag85A‐ESAT‐6 of Mycobacterium tuberculosis

Deng, Y.-H., Sun, Z.-Q., Yang, X., & Bao, L. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02444.x · Cited by 17 · see citing works

Accelerated induction of mycobacterial antigen‐specific CD8+ T cells in the Mycobacterium tuberculosis‐infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette–Guérin

Begum, D., Umemura, M., Yahagi, A., Okamoto, Y., Hamada, S., Oshiro, K., & Matsuzaki, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03141.x · Cited by 17 · see citing works

A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice

Jiang, Q., Zhang, J., Chen, X., Xia, M., Lu, Y., Wen, Q., Ganzhu, F., Zhao, D., Li, Y., He, F., et al. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120114 · Cited by 17 · see citing works

Distinct polyfunctional CD4+ T cell responses to BCG, ESAT-6 and CFP-10 in tuberculous pleurisy

Li, L., Qiao, D., Li, Q., Zhang, X., Lao, S., & Wu, C. Y. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.11.004 · Cited by 15 · see citing works

Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy

Latorre, I., Altet, N., de Souza-Galvão, M. L., Ruíz, J., Lacoma, A., Prat, C., Pérez, M., Ausina, V., & Domínguez, J. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.611167 · Cited by 13 · see citing works

Characterization of particles fabricated with poly(D,L-lactic-co-glycolic acid) and an ornithine–histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cells

Zheng, Y., Kovacs, J. R., Gawalt, E. S., Shen, H., & Meng, W. S. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206778937217 · Cited by 11 · see citing works

A novel DNA vaccine containing multiple TB‐specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG

Gao, H., Li, K., Yu, S., & Xiong, S. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2009.00157.x · Cited by 9 · see citing works

Nanoparticle vaccines

Zhao, L., Seth, A., Wibowo, N., Zhao, C., Mitter, N., Yu, C., & Middelberg, A. P. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 928 · see citing works

Biomedical Applications of Chitosan and Its Derivative Nanoparticles

Zhao, D., Yu, S., Sun, B., Gao, S., Guo, S., & Zhao, K. (2018) · Polymers · doi:10.3390/polym10040462 · Cited by 607 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Nanoparticle Vaccines Against Infectious Diseases

Pati, R., Shevtsov, M. A., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 515 · see citing works

Nanoparticle-Based Delivery Systems for Vaccines

Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. K. (2022) · Vaccines · doi:10.3390/vaccines10111946 · Cited by 267 · see citing works

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

Fries, C. N., Curvino, E. J., Chen, J., Permar, S. R., Fouda, G. G., & Collier, J. H. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0739-9 · Cited by 246 · see citing works

Nanoparticles and Vaccine Development

Kheirollahpour, M., Mehrabi, M., Dounighi, N. M., Mohammadi, M., & Masoudi, A. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666191024162042 · Cited by 195 · see citing works

Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation

Chattopadhyay, S., Chen, J.-Y., Chen, H., & Hu, C. J. (2017) · Nanotheranostics · doi:10.7150/ntno.19796 · Cited by 167 · see citing works

Advancements in prophylactic and therapeutic nanovaccines

Bhardwaj, P., Bhatia, E., Sharma, S., Ahamad, N., & Banerjee, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.020 · Cited by 155 · see citing works

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy

Han, X., Alu, A., Liu, H., Shi, Y., Wei, X., Cai, L., & Wei, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.011 · Cited by 159 · see citing works

Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients

Itani, R., Tobaiqy, M. A., & Faraj, A. A. (2020) · Theranostics · doi:10.7150/thno.46691 · Cited by 146 · see citing works

Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases

Torres-Sangiao, E., Holban, A. M., & Gestal, M. C. (2016) · Molecules · doi:10.3390/molecules21070867 · Cited by 127 · see citing works

Recent advances on chitosan as an adjuvant for vaccine delivery

Dmour, I. M., & Islam, N. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.129 · Cited by 123 · see citing works

Nanoengineering of vaccines using natural polysaccharides

Cordeiro, A. S., Alonso, M. J., & de la Fuente, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.010 · Cited by 117 · see citing works

Evaluation of antibacterial efficiency of chitosan and chitosan nanoparticles on cariogenic Streptococci: an in vitro study

Aliasghari, A., Khorasgani, M. R., Vaezifar, S., Rahimi, F., Younesi, H., & Khoroushi, M. (2016) · Europe PMC (PubMed Central) · doi:10.5281/zenodo.3342596 · Cited by 113 · see citing works

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity

Singha, S., Shao, K., Ellestad, K. K., Yang, Y., & Santamaría, P. (2018) · ACS Nano · doi:10.1021/acsnano.8b05950 · Cited by 110 · see citing works

The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant

Wang, J., Zhu, R., Gao, B., Wu, B., Li, K., Sun, X., Liu, H., & Wang, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.060 · Cited by 107 · see citing works

Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale

Rosenthal, J. A., Chen, L., Baker, J. L., Putnam, D. A., & DeLisa, M. P. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.11.005 · Cited by 92 · see citing works

DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy

Tiptiri-Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.004 · Cited by 92 · see citing works

Polymer nanotechnology based approaches in mucosal vaccine delivery: Challenges and opportunities

Sharma, R. K., Agrawal, U., Mody, N., & Vyas, S. P. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.004 · Cited by 91 · see citing works

Organic and inorganic nanoparticle vaccines for prevention of infectious diseases

Poon, C. J., & Patel, A. (2020) · Nano Express · doi:10.1088/2632-959x/ab8075 · Cited by 82 · see citing works

Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines?

Khademi, F., Taheri, R. A., Avarvand, A. Y., Vaez, H., Momtazi‐Borojeni, A. A., & Soleimanpour, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.035 · Cited by 67 · see citing works

Recent Advances and Future Perspectives in Polymer-Based Nanovaccines

Pippa, Ν., Gazouli, M., & Pispas, S. (2021) · Vaccines · doi:10.3390/vaccines9060558 · Cited by 65 · see citing works

Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems

Tahamtan, A., Ghaemi, A., Gorji, A., Kalhor, H. R., Sajadian, A., Tabarraei, A., Moradi, A., Atyabi, F., & Kelishadi, M. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0069-z · Cited by 63 · see citing works

Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria

Osterloh, A. (2022) · Vaccines · doi:10.3390/vaccines10050751 · Cited by 63 · see citing works

Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks

Tatara, A. M. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0094 · Cited by 52 · see citing works

Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions

Wu, H., Fu, X., Zhai, Y., Gao, S., Yang, X., & Zhai, G. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100299 · Cited by 49 · see citing works

Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective

Gholap, A. D., Gupta, J., Kamandar, P. A., Bhowmik, D. D., Rojekar, S. V., Faiyazuddin, M., Hatvate, N. T., Mohanto, S., Ahmed, M. G., Subramaniyan, V., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01247 · Cited by 45 · see citing works

Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine

Chehelgerdi, M., & Doosti, A. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00618-1 · Cited by 44 · see citing works

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

Xu, K., Liang, Z. C., Ding, X., Hu, H., Liu, S., Nurmik, M., Bi, S., Hu, F.-S., Ji, Z., Ren, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700509 · Cited by 44 · see citing works

Prophylactic vaccine delivery systems against epidemic infectious diseases

Pan, C., Yue, H., Zhu, L., Ma, G., & Wang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113867 · Cited by 43 · see citing works

Nano-antimicrobials: A new paradigm for combating mycobacterial resistance.

Minakshi, P., Ghosh, M., Brar, B., Kumar, R., Lambe, U., Ranjan, K., Prasad, G., & Manoj, J. (2019) · Current pharmaceutical design · doi:10.2174/1381612825666190620094041 · Cited by 18 · see citing works

Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development

Tejeda‐Mansir, A., García‐Rendón, A., & Guerrero‐Germán, P. (2018) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2018.1560552 · Cited by 32 · see citing works

Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives

Chen, M., Shou, Z., Jin, X., & Chen, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2089294 · Cited by 32 · see citing works

DNA vaccines against tuberculosis

Bruffaerts, N., Huygen, K., & Romano, M. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.951630 · Cited by 31 · see citing works

Recent progress in the design of DNA vaccines against tuberculosis.

Sefidi-Heris, Y., Jahangiri, A., Mokhtarzadeh, A., Shahbazi, M., Khalili, S., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Hejazi, M., Hashemzaei, M., et al. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.005 · Cited by 28 · see citing works

Development of New Preventive and Therapeutic Vaccines for Tuberculosis

Kwon, B.-E., Ahn, J.-H., Min, S., Kim, H., Seo, J., Yeo, S.-G., & Ko, H. (2018) · Immune Network · doi:10.4110/in.2018.18.e17 · Cited by 30 · see citing works

Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.

Khademi, F., Derakhshan, M., Avarvand, A. Y., & Tafaghodi, M. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.22059.5648 · Cited by 28 · see citing works

Engineered biomaterials for development of nucleic acid vaccines

Yang, H. J., Li, Y., Jin, S., Xu, J., Wang, P. C., Liang, X., & Zhang, X. (2015) · Biomaterials Research · doi:10.1186/s40824-014-0025-8 · Cited by 23 · see citing works

Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review

Danaeifar, M., Negahdari, B., Eslam, H. M., Zare, H., Ghanaat, M., Koushali, S. S., & Malekshahi, Z. V. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03383-x · Cited by 24 · see citing works

Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines

Peletta, A., Lemoine, C., Courant, T., Collin, N., & Borchard, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106699 · Cited by 21 · see citing works

Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation

Desai, D. N., Mahal, A., Varshney, R., Obaidullah, A. J., Gupta, B., Mohanty, P., Pattnaik, P., Mohapatra, N. C., Mishra, S., Kandi, V., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c02030 · Cited by 21 · see citing works

Nanoscience versus Viruses: The SARS‐CoV‐2 Case

Gościańska, J., Freund, R., & Wuttke, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107826 · Cited by 20 · see citing works

Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes

Lin, Q., Zhou, M., Xu, Z., Khanniche, A., Shen, H., & Wang, C. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.008 · Cited by 20 · see citing works

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

Kazakova, A., Zhelnov, P., Sidorov, R. Y., Rogova, A. S., Vasileva, O., Ivanov, R. A., Reshetnikov, V. V., & Muslimov, A. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457327 · Cited by 20 · see citing works

Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape

Luo, X., Zeng, X., Gong, L., Ye, Y., Sun, C., Chen, T., Zhang, Z., Tao, Y., Zeng, H., Zou, Q., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2120565 · Cited by 17 · see citing works

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment

Skwarek, A., Gąsecka, A., Jaguszewski, M. J., Szarpak, Ł., Dzieciątkowski, T., & Filipiak, K. J. (2021) · Archives of Medical Science · doi:10.5114/aoms/142103 · Cited by 17 · see citing works

Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses

Chen, W., Bao, Y., Chen, X., Burton, J. P., Gong, X., Gu, D., Mi, Y., & Bao, L. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0434-x · Cited by 17 · see citing works

Engineered nanoparticles as a precise delivery system in cancer therapeutics

Sharma, R. K., Agrawal, U., Mody, N., Dubey, S., & Vyas, S. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-41532-3.00013-0 · Cited by 16 · see citing works

Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19

Rahman, M. M., Ahmed, M., Islam, M. T., Khan, M. R., Sultana, S., Maeesa, S. K., Hasan, S., Hossain, M. A., Ferdous, K. S., Mathew, B., et al. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210701150315 · Cited by 16 · see citing works

Protective Effect of a Prime-Boost Strategy with the Ts87 Vaccine againstTrichinella spiralisInfection in Mice

Gu, Y., Zhan, B., Yang, Y., Yang, X., Zhao, X., Wang, L., Yang, J., Bi, K., Wang, Y., & Zhu, X. (2014) · BioMed Research International · doi:10.1155/2014/326860 · Cited by 16 · see citing works

Nanometric Biopolymer Devices for Oral Delivery of Macromolecules with Clinical Significance

Maiti, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00006-x · Cited by 16 · see citing works

Biodegradable nanomaterials

Anagnostou, K., Stylianakis, M. Μ., Michaleas, S., & Σκούρας, Α. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816705-2.00005-9 · Cited by 14 · see citing works

Tackling the Problem of Tuberculosis by Nanotechnology

Rai, M., Ingle, A. P., Bansod, S., & Kon, K. V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801317-5.00009-8 · Cited by 14 · see citing works

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis

Maurya, S. K., Aqdas, M., Das, D. K., Singh, S., Nadeem, S., Kaur, G., & Agrewala, J. N. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05372-1 · Cited by 13 · see citing works

Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model

Gupta, J., Pathak, M., Misra, S., & Misra‐Bhattacharya, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142548 · Cited by 12 · see citing works

Chitosan-Based Nanocomposite as Targeted Drug Delivery Carrier

Selvasudha, N., Sweety, J. P., Dhanalekshmi, U. M., & Ruckmani, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-4787-1_4 · Cited by 11 · see citing works

Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease

Biswas, B., Misra, T. K., Ray, D., Majumder, T., Bandyopadhyay, T. K., & Bhowmick, T. K. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123018 · Cited by 10 · see citing works

The Influence of Nanoparticle on Vaccine Responses against Bacterial Infection

Bagheri-Josheghani, S., Bakhshi, B., & Peerayeh, S. N. (2022) · Journal of Nanotechnology · doi:10.1155/2022/6856982 · Cited by 10 · see citing works

A comprehensive analysis of predicted HLA binding peptides of JE viral proteins specific to north Indian isolates

Sharma, P., Saxena, K., Mishra, S. K., & Kumar, A. (2014) · Bioinformation · doi:10.6026/97320630010334 · Cited by 10 · see citing works

Chikungunya Virus Vaccine Development: Through Computational Proteome Exploration for Finding of HLA and cTAP Binding Novel Epitopes as Vaccine Candidates

Sharma, P., Sharma, P., Ahmad, S., & Kumar, A. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10347-0 · Cited by 10 · see citing works

Interactions of chitosan and its derivatives with cells (review)

Zubareva, A. A., & Svirshchevskaya, E. V. (2016) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683816050185 · Cited by 10 · see citing works

Effects of Nanoparticles on Viral Infection — A Review

Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A., & Alam, A. (2020) · NANO · doi:10.1142/s1793292020300030 · Cited by 9 · see citing works

Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model

Contreras-Magallanes, Y. G., Durán-Aguilar, M., Gallegos, S. L. S., Álvarez, Á. H., Andrade-Santillán, F. A., Bárcenas-Reyes, I., Ruíz, S. G., Rodríguez-Hernández, E., Cantó-Alarcón, G. J., & Milián-Suazo, F. (2021) · Animals · doi:10.3390/ani11041046 · Cited by 9 · see citing works

The emergence of nanovaccines as a new paradigm in virological vaccinology: a review

Baruah, C., Das, P., Devi, P., Saikia, P. M., & Deka, B. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00107 · Cited by 8 · see citing works

Top Down Computational Approach: A Vaccine Development Step to Find Novel Superantigenic HLA Binding Epitopes from Dengue Virus Proteome

Sharma, P., Sharma, P., Sheeba, & Kumar, A. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10184-1 · Cited by 8 · see citing works

Application of Nanotechnology in the Treatment of Infectious Diseases: An Overview

Mba, I. E., & Nweze, E. I. (2022) · Springer eBooks · doi:10.1007/978-981-16-9190-4_2 · Cited by 8 · see citing works

Nanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery

Johnson, L. M., Mecham, J. B., Quinn, F. D., & Hickey, A. J. (2019) · KONA Powder and Particle Journal · doi:10.14356/kona.2020013 · Cited by 8 · see citing works

Nanomaterials-based vaccines to target intracellular bacterial pathogens

Files, M. A., Kristjansson, K. M., Rudra, J. S., & Endsley, J. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1040105 · Cited by 7 · see citing works

Analysis of Promiscuous T cell Epitopes for Vaccine Development Against West Nile Virus Using Bioinformatics Approaches

Sharma, P., Sharma, P., Mishra, S. K., & Kumar, A. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9624-2 · Cited by 7 · see citing works

Biomedical applications of electrospun chitosan nanofibers

Moharir, K. S., Kurakula, M., Kale, V., Kenawy, E., Murtuja, S., Ahsan, M. N., Hasnain, M. S., & Nayak, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821058-1.00004-6 · Cited by 6 · see citing works

Biomimetic Nanovaccines: A Novel Approach in Immunization

Khojini, J. Y., Babaei, B., Shakarami, M., Mofidi, M., Tahershamsi, Z., Arjmand, T. F., Tajbakhsh, A., & Hayat, S. M. G. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230529094128 · Cited by 6 · see citing works

Advance in strategies to build efficient vaccines against tuberculosis

Qu, W., Guo, Y., Xu, Y. L., Zhang, J., Wang, Z., Ding, C., & Pan, Y. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.955204 · Cited by 5 · see citing works

Vaccine strategies against cystic fibrosis pathogens

Moigne, V. L., Herrmann, J., & Herrmann, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1102810 · Cited by 5 · see citing works

Sequence and Structure Based Binding Prediction Study of HLA Class I and cTAP Binding Peptides for Japanese Encephalitis Vaccine Development

Sharma, P., Srivastav, S., Mishra, S. K., & Kumar, A. (2016) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-016-9558-0 · Cited by 4 · see citing works

A Medico-Biological Approach to Chitosan Bionanocomposites

Khanna, N., Chatterji, T., Singh, S., & Khanna, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9646-7_3 · Cited by 3 · see citing works

The application of nanoparticle-based delivery systems in vaccine development

Rashidi, N., Nurgali, K., Apostolopoulos, V., & Davidson, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00001-1 · Cited by 3 · see citing works

Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies

Yaraghi, P., Kheyri, A., Mikaeili, N., Boroumand, A., Abbasifard, M., Farhangnia, P., Rezagholizadeh, F., & Khorramdelazad, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140558 · Cited by 3 · see citing works

DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments

Singh, A. K., & Malviya, R. (2022) · Current Gene Therapy · doi:10.2174/1566523223666221219094849 · Cited by 3 · see citing works

Tuberculosis and Nanotechnology: Where shall the Twain meet?

Shafiq, N., Malhotra, S., & Kondel, R. (2013) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1084 · Cited by 3 · see citing works

Role of Microbial Nanotechnology in Diagnostics

Minocha, S., Khadgawat, P., Bhattacharjee, A., Kumar, A., Tripathi, T., Pandey, S., & Tripathi, D. (2021) · Springer eBooks · doi:10.1007/978-981-16-1923-6_12 · Cited by 3 · see citing works

Construction and Immunological Evaluation of Immunostimulatory Nanocomposites with Vaccine Potential

Zhong, M., & Zhuang, G. (2017) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000339 · Cited by 2 · see citing works

Nanopartiküler Aşılar

DÖNMEZ, E., Dolgun, H. T. Y., & Kırkan, Ş. (2021) · Journal of Anatolian Environmental and Animal Sciences · doi:10.35229/jaes.970713 · Cited by 2 · see citing works

Therapeutic Applications of Nanotechnology in the Prevention of Infectious Diseases

Mazumdar, R., & Thakur, D. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-80371-1_10 · Cited by 2 · see citing works

Nanocarriers as delivery tool for COVID-19 drugs

Padhi, S., Azharuddin, M., Behera, A., Zakir, F., Mirza, M. A., Chyad, A. A., Iqbal, Z., & Mansoor, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95574-4.00018-4 · Cited by 2 · see citing works

Exploration of Biocompatibility and Toxicity of Nanomaterials in Diagnosis and Treatment of Infectious Diseases

Puvvada, N., Chandu, B., & Panigrahi, P. K. (2025) · Wiley eBooks · doi:10.1002/9781394200559.ch11 · Cited by 2 · see citing works

Chitosan based nanocarriers for delivery of therapeutic agents

Ogundolie, F. A., Babalola, O. O., Adebayo-Gege, G. I., Alabi, T. D., & Adetunji, C. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13997-0.00019-9 · Cited by 1 · see citing works

Evaluation and comparison of antimicrobial property of chitosan nanoparticles on nickel-titanium archwires: an in vivo study

PATEL, J., Sharma, P., & Patel, K. (2026) · Dental Press Journal of Orthodontics · doi:10.1590/2177-6709.31.1.e2625184.oar · Cited by 1 · see citing works

Functionalized chitosan-G-poly caprolactone vaccine delivery system fabricated to display antigen–antibody immune complexes of Mycobacterium tuberculosis elicits immune response in Ex-vivo model

Rajadas, S. E., Sounderrajan, V., Prabhakaran, R. A., Agrawal, R., Jeyadoss, L., Rajan, M., Parthasarathy, K., & Shakila, H. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00520-x · Cited by 1 · see citing works

Nanotechnology-based interventions for interactions with the immune system

Saha, S., Dasgupta, S., & Barui, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822858-6.00013-3 · Cited by 1 · see citing works

Construction of Eukaryotic Expression Vector and Expression on Mycobacterium bovis ag85a and mpb70 Genes

Hou, S., Wang, C. F., Zheng, Y. R., Guan, J. N., Lin, J. M., Gao, D. M., Gao, Y. H., Hong, X., & Jiang, X. (2013) · Applied Mechanics and Materials · doi:10.4028/www.scientific.net/amm.421.308

Follicular Helper, Follicular Regulatory T cells and the Germinal Center In HIV Vaccine Development

Dent, A. L. (2015) · International Journal of Vaccines and Immunization · doi:10.16966/2470-9948.e101

Local Pulmonary Host‐Directed Therapies for Tuberculosis via Aerosol Delivery

Juarrero, M. G. (2016) · doi:10.1002/9781118943182.ch16

Investigation into Self-Assembling Microcrystals as an alternative to polysaccharide-based conjugate vaccines

Lavelle, S.-W. (2016) · UCL Discovery (University College London)

Nanomedicine progress in prevention, detection, and treatment of tuberculosis

Marutescu, L. G., Frăţiean, D., & Chifiriuc, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816505-8.00011-4

Enfeksiyöz Nekrotik Hepatitis Aşısının Üretiminde Poli (D, L-Laktik-Ko-Glikolik Asit) (PLGA) Biyopolimerinin Adjuvant Etkisinin Araştırılması

AKINCI, Z., & Kalender, H. (2019) · Etlik Veteriner Mikrobiyoloji Dergisi · doi:10.35864/evmd.543182

Nanoparticle theranostics targeting CLEC14A on tumour vasculature

Pearce, J. (2020) · University of Birmingham Institutional Research Archive (University of Birmingham)

BCG Vaccine and New Approaches Against Prevention

KOÇ, A. N. (2014) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2014.123

A proteína ESAT-6 como medida profilática para o controle da tuberculose pulmonar: uma revisão sistemática

Santos, I. L. A. B. D., & Ferreira, E. D. S. (2023) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv21n10-197

Vaccine delivery systems for immunization

Askari, V. R., Yahyazadeh, R., & Rahimi, V. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00005-9

A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice

Jiang, Q., Zhang, J., Chen, X., Xia, M., Lu, Y., Wen, Q., Ganzhu, F., Zhao, D., Li, Y., He, F., et al. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120114 · Cited by 17 · see citing works

Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection

Yu, F., Wang, J., Dou, J., Yang, H., He, X., Xu, W., Zhang, Y., Hu, K., & Gu, N. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.02.015 · Cited by 55 · see citing works

A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge

Gao, H., Yue, Y., Hu, L., Xu, W., & Xiong, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.093 · Cited by 23 · see citing works

ESAT-6 DNA vaccine for Mycobacterium tuberculosis and its humoral and T-cell response as well as its protective efficacy

Hong, C. (2003) · Zhongguo yufang shouyi xuebao

Open Access at PubMed Central

Jianga, Q., Zhanga, J., Chena, X., Xiaa, M., Lua, Y., Qiua, W., Fenga, G., Zhaoa, D., Lia, Y., Hea, F., et al. (2016)